6,7-dimethyl-2,3-dihydro-1H-benzo[d]pyrrolo[1,2-a]imidazol-1-one

ID: ALA1093593

PubChem CID: 46830217

Max Phase: Preclinical

Molecular Formula: C12H12N2O

Molecular Weight: 200.24

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc2nc3n(c2cc1C)C(=O)CC3

Standard InChI:  InChI=1S/C12H12N2O/c1-7-5-9-10(6-8(7)2)14-11(13-9)3-4-12(14)15/h5-6H,3-4H2,1-2H3

Standard InChI Key:  STFLQOZNCYZSLT-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 15 17  0  0  0  0  0  0  0  0999 V2000
    1.7375    1.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1500    2.9958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4849    2.5091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8193    2.5091    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5625    1.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2289    1.2384    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.1487    3.8208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.6400    2.5070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9004    1.7216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7092    1.5558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2583    2.1744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9931    2.9615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1850    3.1236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5383    3.5807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0668    2.0101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  2  7  2  0
  3  1  1  0
  4  5  1  0
  8  9  2  0
  1  5  1  0
  9 10  1  0
 10 11  2  0
  4  2  1  0
 11 12  1  0
  5  6  2  0
 12 13  2  0
 13  8  1  0
  6  9  1  0
 12 14  1  0
  8  4  1  0
 11 15  1  0
M  END

Associated Targets(Human)

SF-295 (48000 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
IGROV-1 (47897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 200.24Molecular Weight (Monoisotopic): 200.0950AlogP: 2.24#Rotatable Bonds:
Polar Surface Area: 34.89Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.78CX LogP: 1.78CX LogD: 1.78
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.65Np Likeness Score: -0.85

References

1. Sondhi SM, Rani R, Singh J, Roy P, Agrawal SK, Saxena AK..  (2010)  Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.,  20  (7): [PMID:20188544] [10.1016/j.bmcl.2010.01.147]

Source